Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aethlon Medical has filed a provisional patent submission for method and apparatus for increasing contaminant clearance rates during extracorporeal fluid treatment with the US Patent and Trademark Office.
Subscribe to our email newsletter
The patent describes technical improvements to the Aethlon Hemopurifier that increase the rate of capture of undesirable blood contaminants including viruses, toxins, and immunosuppressive particles associated with cancer.
James Joyce, chairman and CEO of Aethlon Medical, said: “Our research team has improved the capability of our Hemopurifier to remove contaminants from the blood. The related patent submission reflects an ongoing strategy to protect our developments and further increase the breadth of our intellectual property estate.”